Jody Crane, MD Recognized by Modern Healthcare As One of the 50 Most Influential Clinical Executives

Jody Crane, MD, TeamHealth, Chief Medical Officer, has been recognized by Modern Healthcare as one of this year’s 50 Most Influential Clinical Executives. The complete ranking is featured in the June 21 issue of Modern Healthcare.

The recognition program acknowledges clinicians working in the healthcare industry who are deemed by their peers and an expert panel to be the most influential in terms of demonstrating leadership and impact. Clinical leadership is needed now, more than ever, to champion evidence-based approaches that will mitigate the impact of the pandemic and address the longstanding health inequities that have become even clearer as a result of the crisis.

Dr. Crane’s work to streamline operations positioned and prepared TeamHealth and its clinicians to face the COVID-19 pandemic. Under Dr. Crane’s leadership, TeamHealth was able to maintain high levels of clinical quality throughout the rapidly changing COVID environment. He supported and championed TeamHealth’s 16,000 affiliated physicians and advanced practice clinicians. He helped them weather the mental and physical demands on clinicians as they adapted to both falling volumes in certain locations and surging volumes elsewhere as they cared for critically ill patients impacted by COVID-19.

Thanks to the breadth of TeamHealth’s practice footprint and the creation of an Emerging Infectious Disease Task Force, Dr. Crane championed the sharing of key findings and best practices with all healthcare organizations across the country in which offered opportunities to improve diagnosis, treatment, operations and clinician safety.

In addition to coordinating these large-scale national responses, Dr. Crane continued working clinically at Henrico Doctors’ Hospital in Richmond, Virginia, serving on the frontlines and making a difference in his local community.

“The 2021 class of 50 Most Influential Clinician Executives did not shy away from the challenges of caring for patient populations during a pandemic. They found inspiration in knocking down hurdles and fighting for top quality care for their patients and staff,” said Modern Healthcare editor, Aurora Aguilar.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.